Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-02

FDA Approved: CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves Sun Pharmaceutical Industries' generic calcipotriene and betamethasone dipropionate topical combination for plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcipotriene and Betamethasone Dipropionate (Calcipotriene and Betamethasone Dipropionate)

Snippet

ORIG AP for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE)